metoclopramide has been researched along with glucagon-like peptide 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holst, JJ; Kemmeries, G; Meier, JJ; Nauck, MA | 1 |
| Bellon, M; Fraser, RJ; Holloway, RH; Horowitz, M; Jones, KL; Kuo, P; Rayner, CK; Smout, AJ; Wishart, J | 1 |
1 trial(s) available for metoclopramide and glucagon-like peptide 1
| Article | Year |
|---|---|
Effects of metoclopramide on duodenal motility and flow events, glucose absorption, and incretin hormone release in response to intraduodenal glucose infusion.
Topics: 3-O-Methylglucose; Adult; Blood Glucose; Carbon Radioisotopes; Dopamine Antagonists; Duodenum; Female; Gastric Inhibitory Polypeptide; Gastrointestinal Motility; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucose; Humans; Incretins; Insulin; Male; Metoclopramide; Peristalsis | 2010 |
1 other study(ies) available for metoclopramide and glucagon-like peptide 1
| Article | Year |
|---|---|
Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
Topics: Adult; Blood Glucose; C-Peptide; Cisapride; Domperidone; Eating; Erythromycin; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Infusions, Intravenous; Insulin; Male; Metoclopramide; Peptide Fragments; Placebos; Protein Precursors; Reference Values | 2005 |